We report the first-in-human safety and immunogenicity assessment of a prototype hexon chimeric adenovirus ( Ad ) serotype 5 ( Ad5 ) vector containing the hexon hypervariable regions of Ad serotype 48 ( Ad48 ) and expressing human immunodeficiency virus ( HIV ) type 1 EnvA .